Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Loperamide hydrochloride
Cat. No.:
OB0225LY-0495
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Loperamide hydrochloride is a synthetic, piperidine derivative and opioid agonist with antidiarrheal activity.
Synonym:
Loperamide HCl; R-18553 (hydrochloride); ADL 2-1294; 34552-83-5; loperamide; 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-N, N-dimethyl-2,2-diphenylbutanamide; 4-(4-Chlorophenyl)-N, N-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide
CAS No.:
34552-83-5
Compound CID:
3955
Formula:
C29H34Cl2N2O2
Formula Weight:
513.498
Specification
Relative Density:
1.1905 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Loperamide hydrochloride can be used to study the effects of gut function and microbiota or play an important role in the exploration of drug mechanisms of action.
Library Information
Targets:
Opioid receptor
Receptors:
δ-Opioid receptor; κ-Opioid receptor; μ-Opioid receptor
Pathways:
Endocrinology/Hormones; Autophagy; Neuronal signaling; GPCR/G protein
Plate Number:
AOCL-7
Plate Location:
d7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 116.85 mM
Ethanol Max Solubility:
10.3 mg/mL; 20 mM
